SCHEMBL17596363

SCHEMBL17596363

C=CCN1CCC(C(=O)OC)C1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
FKBP1A P62942 2/20 0.36
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
SLC6A2 P23975 1/20 0.35
CYP1A2 P05177 1/20 0.33
HIF1A Q16665 1/20 0.33
NPSR1 Q6W5P4 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27425673 0.78 FKBP1A (0.52) FKBP1ACYP1A2HIF1AMEN1KMT2A
SCHEMBL15966508 0.77 FPR2 (0.35) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL5048047 0.74 FKBP1A (0.40) FKBP1ACYP1A2HIF1ANPSR1MEN1
SCHEMBL19559460 0.72 MAPT (0.44) SLC6A4SLC6A3SLC6A2CYP1A2HIF1A
SCHEMBL4594212 0.72 PIK3CD (0.55) ALDH1A1MAPT
SCHEMBL3105740 0.72 BRD4 (0.44) FKBP1ASLC6A4SLC6A3SLC6A2CYP1A2
SCHEMBL1551140 0.72 CYP3A4 (0.35) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL15656372 0.71 FKBP1A (0.35) FKBP1ASLC6A4SLC6A3SLC6A2CYP1A2
SCHEMBL19559454 0.70 CYP1A2 (0.38) SLC6A4SLC6A3SLC6A2CYP1A2HIF1A
SCHEMBL1531470 0.70 BRD4 (0.55) ALDH1A1MAPTHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10420849-B2 Pyrrolidone derivatives, oligomers and polymers NANOSYNTHONS LLC (US) 2019-09-24 US disclosed
US-20170246323-A1 PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS NANOSYNTHONS LLC (US) 2017-08-31 US disclosed
EP-3194365-A1 PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS Nanosynthons LLC (US) 2017-07-26 EP disclosed
WO-2016040962-A1 PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS NANOSYNTHONS LLC (US) 2016-03-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170246323-A1 PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS POF1B, VGF, RAB5IF HDAC3 3455/4885HDAC4 4737/4885HDAC1 4328/4885
US-10420849-B2 Pyrrolidone derivatives, oligomers and polymers POF1B, VGF, RAB5IF HDAC3 3455/4885HDAC4 4737/4885HDAC1 4328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.